Shopping Cart
- Remove All
- Your shopping cart is currently empty
BMS961 is a potent and selective retinoic acid receptor gamma (RARγ) agonist (IC50: 30 nM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $123 | 35 days | |
10 mg | $568 | 35 days |
Description | BMS961 is a potent and selective retinoic acid receptor gamma (RARγ) agonist (IC50: 30 nM). |
In vitro | In vitro, the application of BMS961on mouse ear skin was found to cause a significant increase of thymic stromal lymphopoietin (TSLP) transcripts1. In addition, exposure of BMS861 on limbs at low concentration leads to retarded growth of the zeugopod (long bones) and intactness of autopod (paw). However, a high concentration of BMS961treatment caused equal undifferentiation of both limb regions 2. |
In vivo | In WT mice, RARγ agonists BMS961treatment resulted in an increase of the ear TSLP transcripts and serum TSLP, which indicates an involvement of RAR-mediated events in transcriptional activation of TSLP expression1. |
Molecular Weight | 399.46 |
Formula | C23H26FNO4 |
Cas No. | 185629-22-5 |
Relative Density. | 1.241 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: <39.95 mg/mL |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.